Skip to main content

Fortress Biotech, Inc. (FBIO) Stock Forecast

Data as of May 10, 2026

Healthcare · Current price $2.38 (-1.04%)

Consensus Target
Upside
Analysts
1
Rating
Buy(2.00)

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

FBIO vs Sector & Market

MetricFBIOHealthcare AvgLarge Cap Avg
Analyst Rating2.002.242.41
Analyst Count1819
Target Upside+1708.8%+16.4%
P/E Ratio9.173.2927.60

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$19M$19M$19M1
2026-09-30$22M$22M$22M1
2026-12-31$24M$24M$24M1
2027-12-31$145M$145M$146M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$-0.19$-0.19$-0.191
2026-09-30$-0.16$-0.16$-0.161
2026-12-31$-0.14$-0.14$-0.141
2027-12-31$1.51$1.51$1.511

Frequently Asked Questions

What is the analyst consensus for FBIO?

The consensus among 1 analysts covering Fortress Biotech, Inc. (FBIO) is Buy with an average price target of N/A.

How many analysts cover FBIO?

1 analysts have issued ratings for Fortress Biotech, Inc. in the past 12 months.

Is FBIO a buy or sell right now?

Based on 1 analyst ratings, FBIO has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.

What are the earnings estimates for FBIO?

Analysts estimate FBIO will report EPS of $-0.19 for the period ending 2026-06-30, with revenue estimated at $19M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.